Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
History
Business
Sports
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/d9/f0/cc/d9f0cccb-a7c9-fb64-65ac-92679c4ece4a/mza_12688153430826161048.jpeg/600x600bb.jpg
ADVENT On Air
ADVENT Program
20 episodes
3 days ago
The latest updates in type 2 inflammatory science, brought to you by leading experts in the field. The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area. Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com. This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals. ©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2302644 v2.0 07/2023 MAT-US-2304947 v1.0-P Exp. Date 07/07/2025
Show more...
Medicine
Health & Fitness
RSS
All content for ADVENT On Air is the property of ADVENT Program and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The latest updates in type 2 inflammatory science, brought to you by leading experts in the field. The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area. Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com. This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals. ©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2302644 v2.0 07/2023 MAT-US-2304947 v1.0-P Exp. Date 07/07/2025
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/d9/f0/cc/d9f0cccb-a7c9-fb64-65ac-92679c4ece4a/mza_12688153430826161048.jpeg/600x600bb.jpg
Best Practice for CSU - Perspectives from Allergy and Dermatology
ADVENT On Air
28 minutes
3 days ago
Best Practice for CSU - Perspectives from Allergy and Dermatology
Join allergist Dr. Nicole Chase and dermatologist Dr. Jason Hawkes as they dispel common myths in the management of chronic spontaneous urticaria. offering practical, empathetic strategies to move beyond unnecessary diagnostics and delays, focusing instead on urgent treatment escalation and effective management to reduce the profound burden of uncontrolled CSU on patients. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. Speaker disclosures: Nicole Chase, MD, has the following interests to disclose: ALK, Amgen, Apogee, ARS, AstraZeneca, Aquestive, Blueprint, Cogent, Eli Lilly, Genentech, Illuminate Health, Incyte, MJH Life Sciences, Novartis, Onviv, Regeneron, Sanofi, Regeneron, Vindico. Jason Hawkes, MD, MS has the following interests to disclose: Medical Board, National Psoriasis Foundation Scientific Advisory Committee, Apogee, Arcutis Biotherapeutics, Boehringer Ingelheim, Blueprint Medicines, Bristol Myers Squibb, Boxer Capital LLC, Cogent Biosciences, Galderma, Institute for Systems Biology, Janssen, LEO Pharma, Novartis, Regeneron, Sanofi, SUN Pharma, Takeda, UCB. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB- MAT-GLB-2506315 – 1.0 – 01/2026 MAT-US-2514202 v1.0 - P Expiration Date: 12/24/2027
ADVENT On Air
The latest updates in type 2 inflammatory science, brought to you by leading experts in the field. The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area. Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com. This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals. ©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2302644 v2.0 07/2023 MAT-US-2304947 v1.0-P Exp. Date 07/07/2025